Please Wait.....
Report
Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Forecast to 2032
Market Report I 2024-07-15 I 187 Pages I Market Research Future
Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Forecast to 2032
Market Overview
During the forecast period (2023-2032), the Infection Control for the Human and Animal Health Market industry is expected to experience a compound annual growth rate (CAGR) of 8.16%, increasing from USD 9.56 billion in 2023 to USD 20.95 billion.
The Infection Control for the Human and Animal Health Market is significantly influenced by the growing prevalence of infectious diseases. The demand for infection control products and measures has increased as a result of the significant increase in the prevalence of a variety of infectious diseases worldwide in recent years.
The Infection Control for the Human and Animal Health Market is significantly influenced by the increasing awareness of infection control measures. Recent global health crises and pandemics have contributed to heightened public and professional awareness of the significance of infection prevention. A more informed populace and healthcare community have been the result of increased media coverage, educational campaigns, and government initiatives. The critical role of disinfection products, personal protective equipment (PPE), and sterilization equipment in preventing the spread of infectious diseases is being acknowledged by both healthcare professionals and individuals. The demand for advanced and effective infection control solutions is on the rise as a result of the increasing emphasis on infection control protocols in a variety of settings, such as hospitals, clinics, and public spaces.
Market segment insights
Disinfection products, personal protective equipment (PPE), and sterilization equipment comprise the Infection Control for the Human and Animal Health Market, segmented by product.
The Market has been segmented into viral, bacterial, parasitic, and fungal infections based on the nature of infection.
The market is segmented into human healthcare facilities and animal healthcare facilities based on the end user.
Regional Perspectives
The region's increasing advanced healthcare infrastructure, stringent regulations, high awareness of infection control measures, and increasing number of surgical procedures contributed to the North American market's largest market share of over 33.75% in 2022. PPE is frequently employed in orthopedic surgery to prevent infections in both patients and healthcare providers. The American Joint Replacement Registry's 2021 annual report indicates that 2,244,587 hip and knee procedures were conducted.
The European infection control market for human and animal health is expected to experience substantial growth during the forecast year, 2022-2023, as a result of the growing number of infections in the region. The infection control market in Europe, which encompasses both human and animal health, is experiencing a significant surge as a result of the growing awareness of infectious diseases and the necessity for advanced preventive measures. Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland have documented a rise in confirmed cases of E-11 infection in neonates and infants, with a high morbidity and mortality rate, as reported by the World Health Organization on June 26, 2023.
Infection control in both human and animal health is a dynamic and diverse market in the Asia-Pacific region. Effective infection prevention and control measures are in high demand due to the increasing urbanization, significantly expanding population, and increasing awareness of healthcare standards. Asia and the Pacific are home to approximately 4.3 billion individuals, which constitutes 60% of the global population, according to the United Nations Population Fund (UNFPA).
Major Players
Advanced Sterilization Products (US), STERIS plc (Ireland), Getinge AB (Sweden), Virox Technologies, Inc. (Canada), 3M (US), Zoetis Animal Healthcare (US), PeproTech Sciences Inc (Canada), Neogen Corporation (US), Cardinal Health (US), and Stryker (US) are among the key companies in the Infection Control for the Human and Animal Health Market segment.
TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 OVERVIEW
2.2 DATA FLOW
2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE:
2.4 SECONDARY SOURCES:
2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
2.5.1 PRIMARY RESEARCH DATA FLOW:
2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA FORMULATIONLING
2.8.1 MICROECONOMIC FACTOR ANALYSIS:
2.8.2 DATA FORMULATIONLING:
2.9 TEAMS AND ANALYST CONTRIBUTION
3 MARKET DYNAMICS
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES
3.2.2 RISING AWARENESS OF INFECTION CONTROL MEASURES
3.3 RESTRAINTS
3.3.1 COST CONSTRAINTS IN INFECTION CONTROL
3.4 OPPORTUNITY
3.4.1 GROWING DEMAND FOR TECHNOLOGICALLY ADVANCED AND SUSTAINABLE INFECTION CONTROL SOLUTIONS
4 MARKET FACTOR ANALYSIS
4.1 VALUE CHAIN ANALYSIS
4.1.1 R&D
4.1.2 MANUFACTURING
4.1.3 DISTRIBUTION AND SALES
4.1.4 POST-SALES MONITORING
4.2 PORTER'S FIVE FORCES MODEL
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 THREAT OF SUBSTITUTES
4.2.4 BARGAINING POWER OF BUYERS
4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19 ON THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
4.3.1 IMPACT ON SUPPLY CHAIN
4.3.2 IMPACT ON MARKET PLAYERS
5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 DISINFECTION PRODUCTS
5.2.1 LIQUID DISINFECTANTS
5.2.2 DISINFECTANT WIPES
5.2.3 DISINFECTANT SPRAYS
5.2.4 OTHERS
5.3 PERSONAL PROTECTIVE EQUIPMENT (PPE)
5.3.1 GLOVES
5.3.2 MASKS
5.3.3 GOWNS
5.3.4 PROTECTIVE EYEWEAR
5.3.5 OTHERS
5.4 STERILIZATION EQUIPMENT
5.4.1 HEAT STERILIZATION EQUIPMENT
5.4.2 LOW-TEMPERATURE STERILIZATION EQUIPMENT
5.4.3 RADIATION STERILIZATION EQUIPMENT
5.4.4 FILTRATION STERILIZATION EQUIPMENT
5.4.5 OTHERS
6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE
6.1 OVERVIEW
6.2 VIRAL
6.3 BACTERIAL
6.4 PARASITIC
6.5 FUNGAL INFECTIONS
7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER
7.1 OVERVIEW
7.2 HUMAN HEALTHCARE FACILITIES
7.2.1 HOSPITALS & CLINICS
7.2.2 AMBULATORY SURGICAL CENTERS
7.2.3 OTHERS
7.3 ANIMAL HEALTHCARE FACILITIES
7.3.1 VETERINARY HOSPITALS
7.3.2 ANIMAL SHELTERS
7.3.3 FARMING FACILITIES
7.3.4 OTHERS
8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UK
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 JAPAN
8.4.4 AUSTRALIA
8.4.5 SOUTH KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD
8.5.2 MIDDLE EAST & AFRICA
8.5.3 SOUTH AMERICA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2022
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH
10 COMPANY PROFILE
10.1 3M
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 ZOETIS ANIMAL HEALTHCARE
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 PEROTECH SCIENCES INC.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 STERIS PLC
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGY
10.5 GETINGE AB
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGY
10.6 VIROX TECHNOLOGIES, INC.
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 ADVANCED STERILIZATION PRODUCTS
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIES
10.8 NEOGEN CORPORATION
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 CARDINAL HEALTH
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIES
10.10 STRYKER
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LIQUID DISINFECTANTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT WIPES, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT SPRAYS, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY REGION, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GLOVES, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY MASKS, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GOWNS, BY REGION, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PROTECTIVE EYEWEAR, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 18 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HEAT STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 19 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 20 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY RADIATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 21 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FILTRATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 22 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 23 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 24 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VIRAL, BY REGION, 2019-2032 (USD MILLION)
TABLE 25 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY BACTERIAL, BY REGION, 2019-2032 (USD MILLION)
TABLE 26 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PARASITIC, BY REGION, 2019-2032 (USD MILLION)
TABLE 27 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FUNGAL INFECTIONS, BY REGION, 2019-2032 (USD MILLION)
TABLE 28 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 29 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 30 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 31 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 32 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 33 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 34 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 35 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 36 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VETERINARY HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 37 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL SHELTERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 38 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FARMING FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 39 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 40 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 41 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 42 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 43 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 44 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 45 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 46 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 47 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 48 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 49 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 50 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 51 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 52 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 53 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 54 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 55 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 57 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 58 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 59 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 60 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 61 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 62 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 63 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 64 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 65 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 66 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 67 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 68 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 69 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 70 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 71 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 72 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 73 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 74 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 75 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 76 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 77 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 78 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 79 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 80 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 81 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 82 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 83 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 84 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 85 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 86 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 87 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 88 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 89 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 90 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 91 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 92 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 93 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 94 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 95 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 96 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 97 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 98 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 99 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 100 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 101 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 102 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 103 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 104 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 105 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 106 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 107 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 108 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 109 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 110 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 111 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 112 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 113 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 114 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 115 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 116 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 117 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 118 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 119 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 120 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 121 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 122 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 123 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 124 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 125 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 126 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 127 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 128 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 129 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 130 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 131 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 132 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 133 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 134 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 135 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 136 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 137 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 138 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 139 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 140 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 141 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 142 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 143 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 144 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 145 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 146 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 147 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 148 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 149 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 150 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 151 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 152 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 153 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 154 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 155 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 156 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 157 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 158 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 159 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 160 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 161 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 162 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 163 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 164 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 165 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 166 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 167 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 168 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 169 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 170 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 171 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 172 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 173 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 174 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 175 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 176 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 177 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 178 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 179 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 180 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 181 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 182 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 183 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 184 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 185 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 186 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 187 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 188 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 197 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 198 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 199 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 200 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 201 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 202 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 203 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 204 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 205 PUBLIC PLAYERS STOCK SUMMARY
TABLE 206 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 207 PRODUCT LAUNCH
TABLE 208 3M: PRODUCTS OFFERED
TABLE 209 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
TABLE 210 PEROTECH SCIENCES INC.: PRODCUTS OFFERED
TABLE 211 STERIS PLC: PRODCUTS OFFERED
TABLE 212 GETINGE AB: PRODUCTS OFFERED
TABLE 213 VIROX TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 214 ADVANCED STERILIZATION PRODUCTS: PRODUCTS OFFERED
TABLE 215 ADVANCED STERILIZATION PRODUCTS: KEY DEVELOPMENTS
TABLE 216 NEOGEN CORPORATION: PRODUCT OFFERED
TABLE 217 NEOGEN CORPORATION: KEY DEVELOPMENTS
TABLE 218 CARDINAL HEALTH: PRODUCT OFFERED
TABLE 219 CARDINAL HEALTH: KEY DEVELOPMENTS
TABLE 220 STRYKER: PRODUCT OFFERED
TABLE 221 STRYKER: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: STRUCTURE
FIGURE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
FIGURE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)
FIGURE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT, 2022
FIGURE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2022 & 2032 (USD MILLION)
FIGURE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY INFECTION TYPE, 2022
FIGURE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2022 & 2032 (USD MILLION)
FIGURE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY END USER, 2022
FIGURE 13 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2032 (USD MILLION)
FIGURE 14 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION, 2022
FIGURE 15 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 16 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 17 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 18 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 19 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY, 2022
FIGURE 21 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2030 (USD MILLION)
FIGURE 22 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION, 2022
FIGURE 23 INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 24 COMPETITOR DASHBOARD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET
FIGURE 25 3M: FINANCIAL OVERVIEW
FIGURE 26 3M: SWOT ANALYSIS
FIGURE 27 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
FIGURE 28 ZOETIS ANIMAL HEALTHCARE: SWOT ANALYSIS
FIGURE 29 STERIS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 STERIS PLC: SWOT ANALYSIS
FIGURE 31 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GETINGE AB: SWOT ANALYSIS
FIGURE 33 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 NEOGEN CORPORATION: SWOT ANALYSIS
FIGURE 35 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 STRYKER: FINANCIAL OVERVIEW SNAPSHOT
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security